Web Analytics Made Easy - StatCounter
Megapixl
Search results

Illustration: The Protein Pd-1 Is A Checkpoint To Slow Down T-Cells.

ID 128441753 © Juangaertner | Megapixl.com

PD-1 red extends from the surface of a T-cell and interacts with the ligand protein PD-L1 yellow from a antigen presenting cell. Although the T-cell has been activated through the interaction of a T-cell receptor blue and a MHC protein violett, PD-1 regulates these activation down. It is a checkpoint to slow down T-cells.

CATEGORIES

Not to be used in commercial
designs and/or advertisements.
Click here for terms and conditions.
The protein PD-1 is a checkpoint to slow down T-cells.

Royalty-Free

extended licenses

I-EL W-EL P-EL U-EL
Your image is downloading.

Sharing is not just caring, it's also about giving credit - add this image to your page and give credit to the talented photographer who captured it.:

© Juangaertner | Megapixl.com
HTML code

KEYWORDS

accessory adaptive antigen blood cancer cascade cell cells class complex cytotoxic death defense dendritic disease down helper histocompatibility human illness immune immunity immunization innate interferon killer lymphocyte major malignant medicine membrane metastasis mhc molecules natural peptide presentation presenting prevention programmed protein receptor regulation signal stimulation system therapy transduction white

More images on Dreamstime

telepeage logo t and orange sign of vinci brand for highway checkpoint on a toll road
View through the windshield on the road checkpoint moterway in t
CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4, CD152) protein, 3D rendering. CTLA4 blocking antibodies are used in cancer
CTLA-4 Cytotoxic T-lymphocyte-associated protein 4, CD152 protein. CTLA4 blocking antibodies are used in cancer therapy immune.
CTLA-4 Cytotoxic T-lymphocyte-associated protein 4, CD152 protein. CTLA4 blocking antibodies are used in cancer therapy immune.
CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4, CD152) protein. CTLA4 blocking antibodies are used in cancer therapy (immune
CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4, CD152) protein. CTLA4 blocking antibodies are used in cancer therapy (immune
CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4, CD152) protein, 3D rendering. CTLA4 blocking antibodies are used in cancer
CTLA-4 Cytotoxic T-lymphocyte-associated protein 4, CD152 protein. CTLA4 blocking antibodies are used in cancer therapy immune.
CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4, CD152) protein. CTLA4 blocking antibodies are used in cancer therapy (immune
CTLA-4 Cytotoxic T-lymphocyte-associated protein 4, CD152 protein. CTLA4 blocking antibodies are used in cancer therapy immune.
CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4, CD152) protein, 3D rendering. CTLA4 blocking antibodies are used in cancer

Similar Images

Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
Abnormal malignant cells specimen pleural fluid.
Pembrolizumab monoclonal antibody drug protein. Immune checkpoint inhibitor targetting PD-1, used in the treatment of a number of.
The protein PD-1 is a checkpoint to slow down T-cells.

More images by the same author

Astrocyte-neuron communication through chemical signals
Alzheimer disease, the beta-amyloid peptid
Insulin molecules
Structure of a T-cell receptor bound to a cell membrane
T-lymphocytes interacting antigen presenting cells APCs in the
Tau protein phosphorylation leads to disintegration of microtubuli and aggregation to neurofibrillary tangles.
Tapeworm head attached to the intestine
Pyramidal neurons in the cerebral cortex
Antibodies binding to the spike protein of the coronavirus prevent it`s binding to ACE2 on a human cell
T-lymphocyte interacting with an antigen presenting cell APC
Cytokine storm, crucial cytokines involved in inflammation processes
Microglial cell in the resting form
View more